Bonnie Ky Selected Research

Cardiotoxicity

1/2022	Sex-Specific Cardiovascular Risks of Cancer and Its Therapies.
1/2022	Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab.
1/2022	BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors.
1/2022	Cardiovascular Magnetic Resonance in Early Detection of Radiation Associated Cardiotoxicity With Chest Radiation.
4/2021	Damage to cardiac vasculature may be associated with breast cancer treatment-induced cardiotoxicity.
1/2021	A Novel Mouse Model of Radiation-Induced Cardiac Injury Reveals Biological and Radiological Biomarkers of Cardiac Dysfunction with Potential Clinical Relevance.
1/2021	Left ventricular segmental strain and the prediction of cancer therapy-related cardiac dysfunction.
1/2020	Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity.
1/2020	Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy.
12/2019	Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bonnie Ky Research Topics

Disease

61	Neoplasms (Cancer) 01/2022 - 07/2011
38	Breast Neoplasms (Breast Cancer) 02/2022 - 05/2011
36	Heart Failure 01/2022 - 07/2009
33	Cardiotoxicity 01/2022 - 05/2011
20	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 02/2005
10	Cardiomyopathies (Cardiomyopathy) 01/2022 - 08/2013
9	Left Ventricular Dysfunction 01/2022 - 09/2015
8	Chronic Renal Insufficiency 12/2021 - 07/2013
7	Hypertension (High Blood Pressure) 01/2021 - 08/2013
5	Fibrosis (Cirrhosis) 04/2021 - 04/2015
5	Multiple Myeloma 11/2020 - 02/2015
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2008
4	Second Primary Neoplasms (Neoplasms, Second) 01/2022 - 01/2016
4	Inflammation (Inflammations) 07/2020 - 02/2005
3	Fatigue 02/2022 - 01/2018
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
3	Lymphoma (Lymphomas) 01/2022 - 01/2019
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 09/2015
3	Death (Near-Death Experience) 09/2013 - 07/2011
2	Thrombosis (Thrombus) 01/2022 - 08/2013
2	Thromboembolism 01/2022 - 12/2019
2	Stroke (Strokes) 01/2022 - 04/2016
2	Heart Valve Diseases (Valvular Heart Disease) 03/2021 - 01/2021
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 04/2016
2	Atrial Fibrillation 01/2021 - 01/2019
2	Renal Insufficiency (Renal Failure) 01/2021 - 04/2015
2	Dyspnea (Shortness of Breath) 01/2021 - 01/2019
2	COVID-19 06/2020 - 05/2020
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 01/2018
2	Heart Diseases (Heart Disease) 03/2017 - 04/2013
2	Systolic Heart Failure 03/2012 - 03/2010
2	Coronary Disease (Coronary Heart Disease) 04/2010 - 02/2005
1	Pain (Aches) 02/2022
1	Ketosis 01/2022
1	Atherosclerosis 01/2022
1	Venous Thromboembolism 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Hyperbilirubinemia 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022
1	Myocarditis (Carditis) 01/2022

Drug/Important Bio-Agent (IBA)

39	Biomarkers (Surrogate Marker)IBA 12/2021 - 07/2009
25	Trastuzumab (Herceptin)FDA Link 01/2022 - 05/2011
21	AnthracyclinesIBA 01/2022 - 05/2011
17	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 03/2014
15	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2021 - 07/2009
11	pro-brain natriuretic peptide (1-76)IBA 12/2021 - 03/2011
6	Troponin T (Troponin T1)IBA 12/2021 - 01/2019
6	Growth Differentiation Factor 15IBA 07/2020 - 09/2015
6	Troponin IIBA 01/2019 - 05/2011
6	Sunitinib (Sutent)FDA Link 04/2018 - 12/2011
5	Biological ProductsIBA 01/2022 - 03/2012
5	Galectin 3 (LGALS3)IBA 12/2021 - 09/2015
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2017
4	AndrogensIBA 01/2021 - 01/2017
4	Proteasome InhibitorsIBA 01/2021 - 02/2015
4	TroponinIBA 11/2020 - 05/2011
4	Peroxidase (Myeloperoxidase)IBA 01/2019 - 03/2012
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 07/2011
4	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2015 - 07/2011
3	Protons (Proton)IBA 01/2021 - 01/2019
3	Natriuretic PeptidesIBA 11/2020 - 03/2010
3	Pharmaceutical PreparationsIBA 01/2019 - 08/2016
3	C-Reactive ProteinIBA 09/2015 - 03/2012
3	Taxoids (Taxanes)IBA 09/2015 - 09/2012
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	Aromatase InhibitorsIBA 01/2022 - 01/2017
2	Hormones (Hormone)IBA 01/2022 - 07/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 01/2019
2	Tyrosine (L-Tyrosine)FDA Link 02/2021 - 08/2013
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 11/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 11/2020 - 08/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 02/2005
2	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2020 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 09/2012
2	Capecitabine (Xeloda)FDA Link 01/2019 - 12/2017
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 12/2017
2	Bevacizumab (Avastin)FDA Link 01/2019 - 01/2018
2	carfilzomibIBA 03/2018 - 02/2015
2	Angiogenesis InhibitorsIBA 01/2018 - 08/2013
1	Gemtuzumab (Mylotarg)FDA Link 01/2022
1	arylesteraseIBA 01/2022
1	Androgen Receptor AntagonistsIBA 01/2022
1	KetonesIBA 01/2022
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2022
1	Nonesterified Fatty Acids (NEFA)IBA 01/2022

Therapy/Procedure

68	Therapeutics 02/2022 - 02/2005
23	Drug Therapy (Chemotherapy) 02/2022 - 01/2008
14	Radiotherapy 01/2022 - 04/2013
4	Transplantation 09/2013 - 03/2011
3	Heart-Assist Devices 09/2013 - 07/2011
2	Precision Medicine 12/2021 - 01/2019
2	Cell Transplantation 11/2021 - 01/2020
2	Immunotherapy 01/2021 - 12/2019
2	Aftercare (After-Treatment) 10/2019 - 01/2014
2	Secondary Prevention 01/2018 - 07/2017
1	Neoadjuvant Therapy 02/2022